Norway vs Southern Europe: Proportion of the target population who received the final dose of
Norway
91.0%
in 2024
Southern Europe
60.0%
in 2024
Norway rank
9th
Southern Europe rank
7th
Proportion of the target population who received the final dose of over time
- Norway
- Southern Europe
How they compare
Norway currently reports 91.0% against 60.0% in Southern Europe, a difference of 31.0%.
That makes Norway's figure about 1.5 times Southern Europe's.
Across all 15 years both countries report, Norway has been ahead every year.
Norway ranks 9th and Southern Europe ranks 7th of 107 countries.
Norway has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Norway | Southern Europe | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 78.5% | 49.3% | 29.2% | Norway |
| 2020s | 90.6% | 50.6% | 40.0% | Norway |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher proportion of the target population who received the final dose of, Norway or Southern Europe?
- Norway, at 91.0% against 60.0% in Southern Europe as of 2024.
- What is the difference in proportion of the target population who received the final dose of between Norway and Southern Europe?
- 31.0%, with Norway ahead.
- How many years of comparable data are there for Norway and Southern Europe?
- 15 years are reported by both, from 2010 to 2024.
- How do Norway and Southern Europe rank globally for proportion of the target population who received the final dose of?
- Norway ranks 9th and Southern Europe ranks 7th of 107 countries.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Proportion of the target population who received the final dose of human papillomavirus (HPV) vaccine (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.